Close Menu

NEW YORK – Oxford Immunotec said this week it obtained reregistration of its T-Spot.TB test from the Chinese National Medical Products Administration (NMPA) on April 13. The registration remains in place until April 12, 2025, and it will then need to be renewed. The latest reregistration follows a review by the NMPA and an overseas site inspection of the company’s Oxford, UK manufacturing facility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.